找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biotechnology in India - Reworking A Strategy; George John,Amulya K. Panda Book 2024 The Editor(s) (if applicable) and The Author(s), unde

[复制链接]
楼主: hypothyroidism
发表于 2025-3-23 12:59:47 | 显示全部楼层
Marine Biotechnology in India: Status and Unfolding Opportunitiese centrepiece where different disciplines are converging to generate food and wealth..The phenomenal potential of the non-food sector of marine biotechnology unfolds through the promise of new drugs and bioactive compounds. Enzymes from various types of extremophilic marine organisms can lead to ind
发表于 2025-3-23 15:31:12 | 显示全部楼层
Unveiling Fundamentals and Research Opportunities of mRNA Technologyse platforms, manufacturing intricacies, and inherent advantages. Initially conceptualized within the framework of the central dogma of molecular biology in the 1950s–1960s, mRNA serves as an intermediary for genetic information translation into functional proteins. This chapter delves into the vari
发表于 2025-3-23 21:58:52 | 显示全部楼层
Vaccine Research and Development in India for COVID-19 and Influenzathe world’s largest vaccine manufacturers and has successfully vaccinated a large fraction of its population to protect against COVID-19 disease caused by the sarbecovirus, SARS-CoV-2. However, much of this was reliant on formulations developed elsewhere, and before vaccines could be widely deployed
发表于 2025-3-24 02:05:24 | 显示全部楼层
Development of Genetically Engineered Vaccine and Post-Exposure Therapy Against Anthraxcal weapon, research and development of effective vaccines and post-exposure therapeutics has been crucial. Currently available anthrax vaccines such as Anthrax Vaccine Adsorbed (AVA) and Anthrax Vaccine Precipitate (AVP) are tightly regulated and not commercially available. FDA approved prophylacti
发表于 2025-3-24 03:41:48 | 显示全部楼层
发表于 2025-3-24 08:27:38 | 显示全部楼层
发表于 2025-3-24 10:44:06 | 显示全部楼层
发表于 2025-3-24 15:15:46 | 显示全部楼层
发表于 2025-3-24 19:10:38 | 显示全部楼层
Catalysing and Accelerating a New Phase in Indian Biopharmactively through ‘reverse engineering’ skills. A similar success story lies behind biogenerics produced through the biotech route. These remarkable successes have laid a solid foundation for a cash-rich and confident pharmaceutical industry to successfully cater to the ever-growing need for affordabl
发表于 2025-3-25 01:50:24 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-29 09:12
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表